Dr. Jordan Whitlock specializes in pediatric rare diseases. She obtained her doctoral degree in Genetics, Genomics, and Bioinformatics from the University of Alabama at Birmingham. Her expertise lies in generating patient-specific genomic sequencing data and employing computational biology methods to investigate tissue- and cell-type-specific mechanisms that underlie SETBP1-associated diseases and disorders. Her previous work has examined how a patient variant may function in different biological contexts related to SETBP1.

Her passion for rare diseases emerged in 2016, and prior to her Ph.D., she served as a program coordinator at the Hugh Kaul Precision Medicine Institute. In this role, she played a key part in a patient-centered research approach aimed at helping individuals achieve their goals in precision medicine. This involved tasks such as identifying potential candidates for drug repurposing and developing research plans.